What's the Cost of Burkitt's lymphoma Diagnosis and Treatment in India?
Burkitt's lymphoma treatment cost in India typically ranges from $3,200 to $6,000 for intensive chemotherapy courses, while advanced interventions like related-donor bone marrow transplantation run from $25,000 to $28,000. Expenses depend on disease stage, pediatric vs. adult protocols, and hospital tier. Patients often save approximately 60-80% compared to US costs. Top treatment hubs include Delhi, Mumbai, and Gurgaon.
Typical Burkitt's Lymphoma Treatment Costs in India
- Chemotherapy for breast cancer: $3,200 – $6,000
- Allogenic bone marrow transplantation from a related donor: $25,000 – $28,000
- Allogenic bone marrow transplantation from an unrelated donor: $28,000 – $40,000
- Radiation therapy for colorectal cancer: $4,500 – $7,200
Bookimed Expert Insight: Patients requiring specialized pediatric care should consider Dr. Rela Institute, which features a Guinness World Record-holding surgeon. For complex hematology, HCG Manavata Cancer Centre provides access to Dr. Sudarshan Pandit, who has 10 years of specific experience in Burkitt's lymphoma. Centers like Apollo Indraprastha offer 64-slice PET-CT diagnostics at rates significantly lower than US counterparts. JCI-accredited facilities in India ensure international standards for high-intensity protocols.
| India | Turkey | Austria | |
|---|---|---|---|
| Radiation therapy for colorectal cancer | ≈ $4,500 | from $6,000 | from $6,600 |
| Chemotherapy for breast cancer | ≈ $3,200 | from $4,700 | ≈ $9,500 |
| Chemotherapy | from $800 | from $1,000 | from $990 |
| Bone marrow transplantation | from $30,000 | from $25,000 | ≈ $62,000 |
| Autologous bone marrow transplantation | from $16,000 | from $25,000 | ≈ $38,000 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Burkitt's lymphoma treatment and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Burkitt's lymphoma treatment and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Burkitt's lymphoma treatment journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Best Burkitt's lymphoma Treatment Centers in India: 10 Verified Options and Prices
Dr. Rela Institute & Medical Centre
Get a Medical Assessment for Burkitt's lymphoma in India: Consult with Experienced Doctors Now
View all Doctors
Deenadayalan Munirathnam
Pediatric hematologist-oncologist and bone marrow transplant specialist at Global Hospital Mumbai.
- Specializes in treating pediatric hematological cancers
- Expertise in bone marrow transplants for lymphoma patients
- Dedicated to advanced treatment protocols for Burkitt's lymphoma

Girish Badarkhe
16 years of expertise in leukemia, multiple myeloma, and bone marrow transplant – Dr. Badarkhe brings deep hematology-oncology experience to Burkitt's lymphoma cases.
- MBBS degree from Grant Medical College and Sir JJ Hospital
- MD in Pathology from Lokmanya Tilak Municipal Medical College
- DM in Clinical Hematology from Medical College, Calcutta
- Recognized with awards for professionalism and hard work

Gaurav Kharya
Dr. Gaurav Kharya is a pediatric hematologist-oncologist specializing in Burkitt's lymphoma at Artemis Hospitals.
- Specializes in bone marrow transplants
- Focuses on pediatric cases
- Works at Artemis Hospitals, a leading healthcare institution

Sudarshan Pandit
Dr. Sudarshan Pandit is a hematologist and clinical oncologist at HCG Manavata Cancer Centre. He specializes in hemato-oncology and bone marrow transplantation. He treats blood cancers such as leukemia, lymphoma, and myeloma, and manages non-cancerous conditions including aplastic anemia and thrombocytopenia.
- Performs bone marrow transplants for malignant and benign blood disorders.
- Treats Hodgkin’s and Non-Hodgkin’s lymphoma.
- Works at HCG Manavata, an NABH and NABL accredited cancer specialty hospital.
- Practices in a facility that treats over 75,000 patients annually.
Share this content
Video Stories from Bookimed Patients
Anna Leonova
Expert Overview about Burkitt's lymphoma Treatment in India
What is the standard first-line treatment regimen for Burkitt's lymphoma in Indian hospitals?
Standard treatment in India involves intensive short-duration multi-agent chemo-immunotherapy combined with mandatory central nervous system prophylaxis. Indian hospitals primarily utilize R-CODOX-M/R-IVAC or DA-EPOCH-R regimens. These protocols incorporate Rituximab and intrathecal chemotherapy to manage this aggressive malignancy while preventing disease spread.
- Adult regimens: DA-EPOCH-R provides continuous infusion to reduce severe toxicity risks.
- High-risk therapy: R-CODOX-M alternates high-dose methotrexate for patients with high-risk disease.
- Pediatric protocols: Children receive dose-dense alkylators based on Berlin-Frankfurt-Münster or LMB guidelines.
- Supportive care: Mandatory hydration and allopurinol prevent kidney failure from tumor lysis.
Bookimed Expert Insight: Data from top-tier Indian networks like Manipal and Apollo indicates a shift toward DA-EPOCH-R to minimize treatment abandonment. While R-CODOX-M is powerful, its requirement for advanced inpatient monitoring and prolonged stays can be challenging. Facilities like HCG Manavata and Dr. Rela Institute utilize precision technologies like linear accelerators with 1 mm accuracy for targeted cases, ensuring high-density treatment even in resource-limited settings.
Patient Consensus: Patients emphasize that treatment must start immediately after diagnosis as surgery alone is ineffective. They often note that the first chemotherapy cycle is the most critical period, requiring strict medical monitoring for rapid tumor breakdown.
What is the success or survival rate for Burkitt's lymphoma in India?
Indian medical centers report a 3-year survival rate between 66% and 70% for Burkitt lymphoma. Specialized adult cohorts completing intensive therapy achieve a 73% 2-year survival rate. Pediatric success remains high at 70% when patients receive immediate treatment at hematology-oncology facilities.
- Prognostic factors: Reaching complete remission after first-line therapy remains the primary driver of survival.
- Treatment protocols: Intensive chemotherapy combined with Rituximab immunotherapy significantly improves long-term outcomes for patients.
- Specialized procedures: Clinics offer autologous and allogenic bone marrow transplantation for high-risk or relapsed cases.
- Standard diagnostics: Accurate staging involves PET-CT scans, sentinel lymph node biopsy, and hematologist consultations.
Bookimed Expert Insight: Success in India often depends on high-volume centers with dedicated hematology units. Manipal Hospitals and Apollo Hospital Indraprastha each serve over 1,000,000 patients annually. Large networks like these maintain specialized oncology beds and critical care support. This infrastructure is essential for managing the intensive treatment required for Burkitt lymphoma.
Patient Consensus: Patients emphasize that speed is vital because this cancer progresses rapidly. Many note that while chemotherapy is physically demanding, tumor shrinkage often begins shortly after the first cycle.
Why do doctors emphasize central nervous system (CNS) prophylaxis during treatment?
Doctors emphasize central nervous system prophylaxis to prevent cancer cells from hiding in sanctuary sites. The blood-brain barrier blocks standard intravenous chemotherapy from reaching these areas. Preventative treatment targets microscopic disease in the brain and spinal fluid to avoid high-risk relapse.
- Sanctuary sites: Blood-brain barrier creates safe havens where cancer cells escape standard chemotherapy.
- Treatment methods: Oncologists use intrathecal injections or high-dose methotrexate to bypass neurological barriers.
- Survival outcomes: Prophylaxis reduces central nervous system relapse from historical rates of 40% significantly.
- Burkitt lymphoma protocol: High-volume centers like HCG Manavata Cancer Centre strictly prioritize prophylaxis for aggressive lymphomas.
Bookimed Expert Insight: Indian oncology centers often combine specialized radiation technologies with intensive chemotherapy protocols. Dr. Prakash Pandit at HCG Manavata Cancer Centre utilizes Tomotherapy-H for targeted tumor irradiation. This specialized equipment allows for precise dosing near critical nervous system structures. Choosing a clinic with both hematology-oncology and advanced radiation departments ensures seamless delivery of complex prophylaxis protocols.
Patient Consensus: Patients note that nervous system treatment is often more intense than expected. Many wish they had known about the regular lumbar punctures required to keep the spinal fluid clear.
What is the most critical factor determining long-term survival?
Early diagnosis and immediate start of intensive chemotherapy are the most critical factors for long-term Burkitt lymphoma survival. This aggressive cancer doubles in size every 24 hours. Vital survival pillars include sentinel lymph node biopsy, PET-CT staging, and immediate access to hematology-oncology specialist care.
- Treatment speed: Delaying therapy can rapidly change outcomes for this high-grade lymphocytic cancer.
- Specialized regimens: Survival depends on intensive chemotherapy protocols specific to Burkitt, not general lymphoma.
- Center expertise: High-volume centers manage critical complications like tumor lysis syndrome during initial cycles.
- Survival indicators: Rapid treatment response after the first chemotherapy cycle is a primary predictor.
Bookimed Expert Insight: India’s top oncology centers like Apollo and Manipal manage over 1,000,000 patients annually. This massive volume ensures hematologists are prepared for rare, aggressive cancers. We notice that JCI-accredited clinics in Bengaluru and Delhi often offer IBM Watson for precision mapping. This helps doctors select the most effective regimens for rapid-growth tumors faster.
Patient Consensus: Patients emphasize that getting a fast biopsy and starting treatment immediately is life-saving. They note it is vital to find a team ready to handle intense side effects right away.
Is surgery ever required to remove Burkitt's lymphoma tumors?
Surgery is not the primary treatment for Burkitt lymphoma because these tumors respond exceptionally well to chemotherapy. High-volume Indian centers prioritize systemic therapy over surgical resection. Doctors utilize surgery mainly for diagnostic biopsies or emergency complications like bowel obstructions, perforations, or intussusception requiring urgent repair.
- Diagnostic biopsies: Surgeons perform incisional biopsies to confirm rapid-growing hematologic malignancies.
- Emergency complications: Acute surgery resolves life-threatening blocks or ruptures in the intestines.
- Localized debulking: Removing 90% of localized tumors may reduce subsequent chemotherapy intensity.
- Access techniques: Procedures like sentinel lymph node biopsy help stage the cancer accurately.
Bookimed Expert Insight: Indian oncology centers like Artemis and Manipal focus on high-speed diagnostics rather than surgical removal to improve outcomes. Data shows top-tier facilities emphasize starting intensive chemotherapy immediately after biopsy. Centers like Global Hospital Chennai and Apollo Indraprastha handle over 1,000,000 patients annually. This massive volume ensures pathology teams can confirm Burkitt lymphoma quickly. This allows patients to bypass major surgical trauma and move straight to life-saving systemic treatments.
Patient Consensus: Patients note that surgery is almost always just a step for diagnosis or emergencies rather than the cure. They emphasize finding a center that can start chemotherapy quickly once the biopsy results are ready.



















